|
|
|
Sheraton Lisboa Hotel & Spa, Lisboa, Portugal
November 4-8, 2013
PEGS Europe is the largest European event addressing all aspects of protein and antibody engineering. With newly expanded coverage, this year's event will feature 300+ attendees, 100 scientific presentations, 50+ posters, dedicated networking opportunities, exclusive exhibit and poster viewing hours, and interactive roundtable, breakout & panel discussions. Conference Programs: - Novel Antibody Constructs & Alternative Scaffolds
- Cancer Biotherapeutics
- Development of Novel Biotherapeutics
- High-Throughput Protein Expression
- Optimizing Protein Expression
- Difficult to Express Proteins
|
|
|
|
|
|
Organized by:
|
|
Cambridge Healthtech Institute (CHI) |
|
Invited Speakers:
|
|
Keynote Speakers: - Luis Borges, Ph.D., Scientific Director, Therapeutic Innovation Unit, Amgen, Inc.
- Yves Durocher, Ph.D., Protein Expression Team Leader, Life Sciences, NRC Human Health Therapeutics Portfolio, National Research Council Canada
- Dominic Esposito, Ph.D., Director, Protein Expression Laboratory, SAIC-Frederick
- Robert Lutz, Ph.D., Vice President, Translational Research & Development, ImmunoGen, Inc.
- Martine Piccart, M.D., Ph.D., Head, Medical Oncology, Jules Bordet Institute; Chair, ESMO (European Society for Medical Oncology)
- Andreas Plückthun, Ph.D., Director and Professor, Biochemistry, University of Zurich
|
|
|
|
|
|
Deadline for Abstracts:
|
|
October 4, 2013
|
|
|
|
|
|
Registration:
|
|
Register Now
|
|
E-mail:
|
|
kwaterman@healthtech.com
|
|
|
|
|
|
|
|